|
|
The 3rd World Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Hilton Hotel, Prague, Czech Republic, May 13-16, 2010 |
|
| |
| Changing diabetes: new players and existing performers |
 |
|
|
|
Thursday, May 13, 2010, Congress Hall II
|
|
Shifting paradigms in Type 2 diabetes therapy: new goals and options |
|
|
15:00 - 15:05 |
Welcome
Michaela Diamant, The Netherlands |
|
15:05 - 15:20 |
Diabetes treatment challenges in the post-UKPDs era
Marc Evans, UK |
|
|
The enteroinsular axis: insights into incretin physiology
Jens Juul Holst, Denmark |
|
|
Review of incretin treatment options:
DPP-4 inhibitors & GLP-1 receptor agonists
Stephen Gough, UK |
|
|
Liraglutide vs sitagliptin:
results from a randomised head to head trial
Melanie Davies, UK |
|
|
Clinical experience with liraglutide
Mark Edwards, UK |
|
|
Panel discussion |
|
17:00 - 17:30 |
Break |
|
Insulin therapy keeping pace with glycaemia: existing options and novel formulations |
|
17:30 - 17:35 |
Welcome
Jiten Vora, UK |
|
17:35 - 17:50 |
Getting a head start on glycaemia
Itamar Raz, Israel |
|
17:50 - 18:05 |
Taking safety seriously
David Russell-Jones, UK |
|
18:05 - 18:30 |
Getting the regimen right: optimisation, intensification and convenience
Kjeld Hermansen, Denmark and Miguel Brito, Spain |
|
18:30 - 18:45 |
Panel discussion |
|
18:45 - 19:00 |
Future leaps in concept
Tim Heise, Germany |
|
|
|
|
WebStudio.co.il